Ultragenyx Pharmaceutical Inc.
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Sen. Rick Scott Joins Sen. Rand Paul & Rep. Kat Cammack to Introduce[...]
06/14/2021 | Press release | Distributed by Public on 06/14/2021 04:34
Please select the service you want to use:
Smartlinks | BiomX Inc. | News | Health | Healthcare Policy | Science | Biology | Research | Local News | Politics and Policy | Healthcare Policy | Policy and Regulation | Business and Economy | Finance | Stock Markets | Security Markets | Stock Markets | Security Markets | Company News | Top Company News | Business Announcement | Products and Services | Corporate Litigation and Regulation | Pharmaceuticals | Public Companies | Biotechnology and Medical Research Companies | Shell and Capital Pool Companies | New York Stock Exchange (NYSE) | Tel Aviv Stock Exchange (TASE) | NYSE American | NYSE ARCA Equities | BZX Exchange | BYX Exchange | EDGA Exchange | EDGX Exchange | NYSE National | Nasdaq BX | Nasdaq PSX | Nasdaq Intermarket | FINRA Alternative Display Facility (ADF) | Investors Exchange (IEX) | NYSE Chicago
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact